Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease
Jannis Kountouras(Aristotle University of Thessaloniki), Ifigenia Michailidou(Aristotle University of Thessaloniki), Marina Boziki(Aristotle University of Thessaloniki), Dimitrios Tzilves(Aristotle University of Thessaloniki), Panagiotis Katsinelos, Athina Zabouri(Aristotle University of Thessaloniki), Christos Zavos(Aristotle University of Thessaloniki), Georgia Deretzi(AHEPA University Hospital), Magda Tsolaki(Aristotle University of Thessaloniki), Nikolaos Grigoriadis(Unknown), Emmanuel Gavalas(Aristotle University of Thessaloniki), Dimitrios Chatzopoulos(Aristotle University of Thessaloniki)
Cited by 114
Related Papers
Where are Europe’s last primary forests?
|Diversity and Distributions|2018|454
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
|Archives of General Psychiatry|2010|402
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
|Journal of Neurology Neurosurgery & Psychiatry|2014|355
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2021|354
Adipokines in nonalcoholic fatty liver disease
|Metabolism|2015|353